Does size matter? Right ventricular mass and pulmonary vascular resistance in heart transplantation
A retrospective study analyzing the relationship between the donor-to-recipient right ventricular mass (RVM) ratio and the recipient’s pre-transplant pulmonary vascular resistance (PVR), proposing that PVR may influence the effect of this RVM ratio on post-transplant outcomes.
Angioplasty in patients with previous surgical revascularization: graft vs. native vessel?
This multicenter retrospective observational study from Australia compares the outcomes of angioplasty performed on grafts (primarily saphenous vein grafts) versus native vessels. It analyzes clinical and angiographic characteristics, adverse events, and short- and long-term mortality.
Safe early discharge after TAVI: is it possible?
A retrospective observational study evaluating patients who underwent TAVI to identify predictive factors for atrioventricular block (AVB) within 24 hours to 30 days post procedure and to develop a risk stratification tool.
The diabetic paradox in coronary revascularization surgery
Analysis of the outcomes of the observational PRIORITY cohort, focusing on the 10-year results of patients undergoing coronary revascularization surgery and assessing the impact of diabetes mellitus.
Game of grafts: is winter coming for conventional aortic arch surgery?
This study evaluates the feasibility and early outcomes of total endovascular aortic arch repair in patients deemed unfit for open surgery.
Potential of arterial grafts in acute myocardial infarction: benefits and realities
Comparative short- and mid-term outcomes in patients with acute myocardial infarction undergoing coronary artery bypass grafting with single or multiple arterial grafts.
Atrioventricular block after congenital heart surgery
A single-center retrospective study analyzing the incidence of postoperative atrioventricular block (AVB) based on the initial diagnosis and recovery time.
Tricuspid regurgitation: guidelines, definitions, and current treatment alternatives. An expert opinion.
Dr. Juan Diego Sánchez’s perspective on the current state of the art in tricuspid regurgitation treatment.
